I3 PHARMACEUTICALS H-1B Visa Sponsorship & Salary Data

The median H-1B salary at I3 PHARMACEUTICALS is $79,914, based on 20 certified filings from FY 2020 to FY 2026. This is 33% lower than the national H-1B median salary of $120,000. Compensation at I3 PHARMACEUTICALS reflects their market positioning, with entry-level roles starting around $76,149 and senior positions reaching $150,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at I3 PHARMACEUTICALS range from $58,822 at the 10th percentile to $150,000 at the 90th percentile, showing a $91,178 spread across experience levels and roles. The 25th percentile is $76,149 and the 75th percentile is $99,986.

Yes, I3 PHARMACEUTICALS actively sponsors H-1B visas in FY 2026. In the most recent fiscal year (FY 2026), I3 PHARMACEUTICALS filed 4 H-1B labor condition applications with 4 certified and 0 denied, at a median salary of $65,000. Across FY 2020–2026, they have filed 22 total H-1B applications with 20 certified and a 0% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. I3 PHARMACEUTICALS sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), I3 PHARMACEUTICALS filed 4 H-1B applications, with 4 certified and 0 denied. Over 7 years of data, I3 PHARMACEUTICALS has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

I3 PHARMACEUTICALS's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 22 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating I3 PHARMACEUTICALS as a potential H-1B sponsor.

This is an excellent approval rate, indicating I3 PHARMACEUTICALS has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

I3 PHARMACEUTICALS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 20 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles I3 PHARMACEUTICALS most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at I3 PHARMACEUTICALS:

The most frequently sponsored role is Senior Research Scientist with 7 filings at a median salary of $82,514. This is followed by Research Scientist I (3 filings) and Senior Analytical Documentation Specialist.

I3 PHARMACEUTICALS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where I3 PHARMACEUTICALS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top I3 PHARMACEUTICALS H-1B locations:

The largest H-1B hub for I3 PHARMACEUTICALS is Warminster, PA with 20 filings at a median salary of $79,914.

I3 PHARMACEUTICALS's median H-1B salary has changed by -15% from FY 2020 ($76,149) to FY 2026 ($65,000). Tracking salary trends over time reveals how I3 PHARMACEUTICALS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at I3 PHARMACEUTICALS.

Year-by-year breakdown:

• FY 2022: $79,914 (3 certified)
• FY 2023: $82,514 (3 certified)
• FY 2024: $112,674 (3 certified)
• FY 2025: $101,504 (2 certified)
• FY 2026: $65,000 (4 certified)

Salary levels have remained relatively stable at I3 PHARMACEUTICALS.

I3 PHARMACEUTICALS primarily files H-1B applications at Wage Level II, accounting for 55% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making I3 PHARMACEUTICALS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

I3 PHARMACEUTICALS has a mix of entry-level (Level I) and experienced (Level II+) H-1B positions. This reflects a range of roles from junior to senior.

I3 PHARMACEUTICALS's median H-1B salary of $79,914 is 33% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating I3 PHARMACEUTICALS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare I3 PHARMACEUTICALS's offerings with similar companies in your field for a more accurate assessment.

I3 PHARMACEUTICALS's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. I3 PHARMACEUTICALS files 25% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 20 certified filings, I3 PHARMACEUTICALS invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.